Halozyme Therapeutics shares owned by Amalgamated Bank
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Amalgamated Bank
from 13F filings
Historical chart of Amalgamated Bank investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Amalgamated Bank consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by Amalgamated Bank
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $2.8M | 69k | 40.69 |
2023-12-31 | $3.1M | 83k | 36.96 |
2023-09-30 | $3.2M | 84k | 38.20 |
2023-06-30 | $3.1M | 86k | 36.08 |
2023-03-31 | $3.4M | 90k | 38.19 |
2022-12-31 | $5.4M | 95k | 56.90 |
2022-09-30 | $3.8M | 96k | 39.54 |
2022-06-30 | $4.1M | 94k | 44.00 |
2022-03-31 | $3.8M | 95k | 39.88 |
2021-12-31 | $4.0M | 100k | 40.21 |
2021-09-30 | $4.1M | 101k | 40.68 |
2021-06-30 | $4.8M | 106k | 45.41 |
2021-03-31 | $835k | 20k | 41.69 |
2020-12-31 | $935k | 22k | 42.70 |
2020-09-30 | $555k | 21k | 26.28 |
2020-06-30 | $583k | 22k | 26.81 |
2020-03-31 | $447k | 25k | 18.00 |
2019-12-31 | $477k | 27k | 17.73 |
2019-09-30 | $393k | 25k | 15.50 |
2019-06-30 | $441k | 26k | 17.18 |
2019-03-31 | $305k | 19k | 16.09 |
2018-12-31 | $266k | 18k | 14.63 |
2018-06-30 | $321k | 19k | 16.85 |
2018-03-31 | $313k | 16k | 19.59 |
2017-12-31 | $329k | 16k | 20.25 |
2017-09-30 | $264k | 15k | 17.35 |
2017-06-30 | $180k | 14k | 12.80 |
2017-03-31 | $173k | 13k | 12.95 |
2016-12-31 | $132k | 13k | 9.87 |
2016-09-30 | $139k | 12k | 12.05 |
2016-06-30 | $117k | 12k | 10.16 |
2016-03-31 | $106k | 11k | 9.48 |
2015-12-31 | $176k | 10k | 17.31 |
2015-09-30 | $150k | 11k | 13.45 |
2015-06-30 | $248k | 11k | 22.60 |
2015-03-31 | $150k | 11k | 14.28 |
2014-12-31 | $97k | 10k | 9.60 |
2014-09-30 | $92k | 10k | 9.12 |
2014-06-30 | $100k | 10k | 9.91 |